Michael L Mohler

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Journal of medicinal chemistry

International journal of molecular sciences

University of Tennessee Health Science Center

University of Tennessee Health Sciences Library (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tennessee Health Science Center Jul 01 2011

United States

Assistant Professor (volunteer) :: Pharmaceutical Sciencs

GTx Inc Jun 01 2004

United States

Senior Scientist I, Intellectual Property and Medicinal Chemistry

Walgreen Co Dec 01 1998 - May 01 2011

United States

part-time pharmacist :: Pharmacy

Education History

University of Tennessee Health Sciences Library Aug 01 1998 - May 01 2005

United States

PHD :: Pharmaceutical Sciences (Medicinal Chemistry Division)

University of Tennessee Knoxville Aug 01 1995 - May 01 1998

United States

MSC :: Biochemistry

University of Tennessee at Martin Aug 01 1989 - May 01 1994

United States

BSC :: Chemistry and Biology

Publications

Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Michael L Mohler, Ramesh Narayanan, Duane D Miller
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer. Journal of medicinal chemistry 66 (5) (2023)
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Michael L Mohler, Ramesh Narayanan, Duane D Miller
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer. Journal of medicinal chemistry 66 (5) (2023)
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Michael L Mohler, Ramesh Narayanan, Duane D Miller
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer. Journal of medicinal chemistry 66 (5) (2023)
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Michael L Mohler, Ramesh Narayanan, Duane D Miller
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer. Journal of medicinal chemistry 66 (5) (2023)
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Michael L Mohler, Ramesh Narayanan, Duane D Miller
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluation for Activity against Enzalutamide-Resistant Prostate Cancer. Journal of medicinal chemistry (2023)
Yali He, Dong-Jin Hwang, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Michael L Mohler, Ramesh Narayanan, Duane D Miller
Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer. Journal of medicinal chemistry 64 (15) (2021)
Michael L Mohler, Arunima Sikdar, Suriyan Ponnusamy, Dong-Jin Hwang, Yali He, Duane D Miller, Ramesh Narayanan
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer. International journal of molecular sciences 22 (4) (2021)
Dong-Jin Hwang, Yali He, Suriyan Ponnusamy, Michael L Mohler, Thirumagal Thiyagarajan, Iain J McEwan, Ramesh Narayanan, Duane D Miller
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity. Journal of medicinal chemistry 62 (2) (2018)

Michael L Mohler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael L Mohler